Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.

[1]  N. Probst-Hensch,et al.  IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas. , 2009, Human pathology.

[2]  G. Kristiansen,et al.  Expression of CD24, P-cadherin and S100A4 in tumors of the ampulla of Vater , 2009, Modern Pathology.

[3]  T. Nakajima,et al.  CD24 Expression Is a Novel Prognostic Factor in Esophageal Squamous Cell Carcinoma , 2009, Annals of Surgical Oncology.

[4]  H. Lee,et al.  Expression of CD24 in clear cell renal cell carcinoma and its prognostic significance. , 2008, Urology.

[5]  R. Cartun,et al.  KOC (K homology domain containing protein Overexpressed in Cancer) and S100A4‐protein immunoreactivity improves the diagnostic sensitivity of biliary brushing cytology for diagnosing pancreaticobiliary malignancies , 2008, Diagnostic cytopathology.

[6]  Y. Jeng,et al.  Cytoplasmic CD24 Expression Is a Novel Prognostic Factor in Diffuse-Type Gastric Adenocarcinoma , 2007, Annals of Surgical Oncology.

[7]  R. Cartun,et al.  S100A4 protein and mesothelin expression in dysplasia and carcinoma of the extrahepatic bile duct. , 2007, American journal of clinical pathology.

[8]  L. Roberts,et al.  An assessment of chromosomal alterations detected by fluorescence in situ hybridization and p16 expression in sporadic and primary sclerosing cholangitis-associated cholangiocarcinomas. , 2007, Human pathology.

[9]  T. Khoury,et al.  CD24 Expression is an Independent Prognostic Marker in Cholangiocarcinoma , 2007, Journal of Gastrointestinal Surgery.

[10]  G. Gores,et al.  Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures. , 2006, Gastroenterology.

[11]  N. Kapucuoglu,et al.  CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study. , 2006, Pathology, research and practice.

[12]  Hanina Hibshoosh,et al.  CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis. , 2006, Gastroenterology.

[13]  K. Lillemoe,et al.  Telomere length variation in biliary tract metaplasia, dysplasia, and carcinoma , 2006, Modern Pathology.

[14]  G. Christofori.  New signals from the invasive front , 2006, Nature.

[15]  Y. Jeng,et al.  CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma. , 2006, Cancer letters.

[16]  W. Weichert,et al.  Cytoplasmic CD24 Expression in Colorectal Cancer Independently Correlates with Shortened Patient Survival , 2005, Clinical Cancer Research.

[17]  Carmen Jerónimo,et al.  P-Cadherin Overexpression Is an Indicator of Clinical Outcome in Invasive Breast Carcinomas and Is Associated with CDH3 Promoter Hypomethylation , 2005, Clinical Cancer Research.

[18]  Alfredo De Lillo,et al.  P-cadherin expression and survival rate in oral squamous cell carcinoma:an immunohistochemical study , 2005, BMC Cancer.

[19]  Yusuke Nakamura,et al.  Genome‐wide analysis of gene expression in human intrahepatic cholangiocarcinoma , 2005, Hepatology.

[20]  H. Nagai,et al.  Immunohistochemical study of characteristics of bile duct dysplasia evaluated on the basis of expression of metastasis/invasion-related factors and p53. , 2004, Journal of hepato-biliary-pancreatic surgery.

[21]  T. Therneau,et al.  A Comparison of Routine Cytology and Fluorescence in situ Hybridization for the Detection of Malignant Bile Duct Strictures , 2004, The American Journal of Gastroenterology.

[22]  I. Wistuba,et al.  Gallbladder cancer: lessons from a rare tumour , 2004, Nature Reviews Cancer.

[23]  K. Tsuneyama,et al.  Expression of MAGE‐A3 in intrahepatic cholangiocarcinoma and its precursor lesions , 2004, Pathology international.

[24]  S. Loening,et al.  CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer , 2004, The Prostate.

[25]  S. Yao,et al.  Expression of Bcl-2 and Bax in extrahepatic biliary tract carcinoma and dysplasia. , 2003, World journal of gastroenterology.

[26]  C. Pilarsky,et al.  CD24 expression is a new prognostic marker in breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  C. Maccalman,et al.  Cadherin switching in ovarian cancer progression , 2003, International journal of cancer.

[28]  G. Kristiansen,et al.  Tumour Biological Aspects of CD24, A Mucin-Like Adhesion Molecule , 2003, Journal of Molecular Histology.

[29]  I. Petersen,et al.  CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients , 2003, British Journal of Cancer.

[30]  C. Pilarsky,et al.  CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. , 2002, The American journal of pathology.

[31]  W. Kim,et al.  Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma. , 2002, Human pathology.

[32]  T. P. Pretlow,et al.  Aberrant P-cadherin expression is an early event in hyperplastic and dysplastic transformation in the colon , 2002, Gut.

[33]  Y. Jan,et al.  Human REG I gene is up‐regulated in intrahepatic cholangiocarcinoma and its precursor lesions , 2001, Hepatology.

[34]  N. Rosenblum,et al.  Cadherin expression in glandular tumors of the cervix , 2000, Cancer.

[35]  T. Yagi,et al.  Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. , 2000, Genes & development.

[36]  J. Kononen,et al.  Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.

[37]  J. Espada,et al.  Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features. , 1995, The American journal of pathology.

[38]  A. Wee,et al.  An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas , 1994, Cancer.

[39]  S. Hirohashi,et al.  Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. , 1989, Cancer research.

[40]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[41]  Stanley R. Hamilton,et al.  Pathology and genetics of tumours of the digestive system , 2000 .